- Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
- Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
- Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
- Telesis Bio Reports Third Quarter 2023 Financial Results
- Telesis Bio to Report Third Quarter Financial Results on Monday, November 13, 2023
- Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA
- Telesis Bio Announces Commercial Release of BioXp® NGS Library Prep Kit for WGS
- Telesis Bio Appoints William J. Kullback Chief Financial Officer
- Telesis Bio Reports Second Quarter 2023 Financial Results
- Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
More ▼
Key statistics
As of last trade, Telesis Bio Inc (TBIO:NSQ) traded at 0.3666, 22.32% above the 52 week low of 0.2997 set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.34 |
---|---|
High | 0.38 |
Low | 0.34 |
Bid | 0.3649 |
Offer | 0.3779 |
Previous close | 0.3395 |
Average volume | 96.86k |
---|---|
Shares outstanding | 30.10m |
Free float | 18.76m |
P/E (TTM) | -- |
Market cap | 10.22m USD |
EPS (TTM) | -1.64 USD |
Data delayed at least 15 minutes, as of Apr 30 2024 19:04 BST.
More ▼